Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001178913-26-002062
Filing Date
2026-04-10
Accepted
2026-04-10 16:07:07
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 8956
  Complete submission text file 0001178913-26-002062.txt   10588
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV Israel
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV Israel 972-77-331-0156
Chemomab Therapeutics Ltd. (Issuer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 16 KANFEY NESHARIM ST. RAMAT GAN L3 5235716
Business Address
Fatal Sigal (Reporting) CIK: 0001850994 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38807 | Film No.: 26854898